['Intrahepatic cholestasis of pregnancy (ICP) affects 0.2-2% of pregnant women. While the maternal clinical course of ICP is usually benign, the fetal effects can be severe spanning from spontaneous preterm birth to fetal demise to long term effects on the health of the progeny. ICP is characterized by high maternal serum levels of bile acids and placental and hepatic bile acids accumulation. Intrahepatic cholestasis, in the non-pregnant state, has been also linked to alterations of the mitochondrial activity attributed to high oxidative stress rates driven by high intracellular bile acids concentrations. Here we explored the hypothesis that elevated bile acid levels of ICP modify the placental mitochondrial activity.', 'By using a set of 12 ICP and 12 control placenta samples, we assessed the expression of all 13 mitochondrial-encoded protein-coding genes and the mitochondrial DNA (mtDNA) relative abundance by real-time PCR. We also assessed the oxidative stress status by measuring DNA damage by ELISA.', 'We determined that: 1) the expression of MT-ND4L (+53% - p\xa0<\xa00.01), MT-ND4 (-19%-0.05\xa0<\xa0p\xa0≤\xa00.01), MT-ND5 (+40% - p\xa0<\xa00.01), MT-CYTB (+35% - p\xa0<\xa00.01) is associated with ICP; 2) the mtDNA relative abundance is not associated with ICP (0.098 in ICP vs 0.118 in controls - p\xa0>\xa00.05); 3) the oxidative stress status is associated with ICP (4403.9\xa0pM 8-oxo-dG/μg DNA in ICP vs 3809.8\xa0pM 8-oxo-dG/μg DNA in controls - p\xa0<\xa00.01).'] Are mitochondrial gene expression profiles associated with intrahepatic cholestasis of pregnancy?